<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01977898</url>
  </required_header>
  <id_info>
    <org_study_id>STU00043549</org_study_id>
    <nct_id>NCT01977898</nct_id>
  </id_info>
  <brief_title>Incidence of Headache Following an Unintentional Dural Puncture</brief_title>
  <official_title>Incidence of Post-Dural Puncture Headache Following Unintentional Dural Puncture: A Randomized Trial of Intrathecal Morphine Versus Saline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of intrathecal morphine administration
      following an unintentional dural puncture, to decrease the incidence of post dural puncture
      headaches (PDPH) in obstetric patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unintentional dural puncture is a known risk of neuraxial techniques, occurring in roughly 1%
      of all epidural catheter placements. The incidence of post dural puncture headaches(PDPH)
      after unintentional dural puncture (UDP) is 50-80%. A PDPH is defined as a headache that
      occurs following a dural puncture, worsens within 15 minutes after sitting or standing and
      improves within 15 minutes after lying, with at least one of the following: neck stiffness,
      tinnitus, hypacusia, photophobia, or nausea. The headache develops within 5 days after dural
      puncture and resolves either spontaneously within 1 week or within 48 hours after effective
      treatment of the spinal fluid leak.

      The rates of PDPH following unintentional dural puncture with placement of an intrathecal
      catheter will be compared in two groups: intrathecal morphine (treatment) versus intrathecal
      saline (control) administered 1-2 hours after delivery, followed by immediate catheter
      removal. Patients randomized to the treatment group (morphine) will receive preservative-free
      morphine 0.3 mL (150 mcg) intrathecally. Those randomized to the control group will receive
      normal saline 0.3 mL intrathecally. After administration of intrathecal morphine, all
      patients will have their respirations monitored every hour for a period of 12 hours and then
      every two hours for a period of 12 hours. On postpartum days 1-5, all patients will be
      visited daily while inpatient and/or contacted by phone after discharge from the hospital.

      PDPH can lead to significant morbidity and negatively impact patient satisfaction with
      postpartum recovery. Along with headache, patients may develop cranial nerve palsy during the
      postpartum period leading to permanent disability. In addition, new mothers are unable to
      bond with their babies due to headache and associated symptoms of nausea, vomiting and
      limited mobility secondary to pain. Therefore, an effective intervention to decrease the risk
      of PDPH after UDP would be useful.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of post dural puncture headaches</measure>
    <time_frame>Delivery - postpartum day 5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of headache</measure>
    <time_frame>Delivery - Postpartum day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Epidural Blood Patch</measure>
    <time_frame>Delivery - Postpartum day 5</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Postdural Puncture Headache</condition>
  <condition>Post-Lumbar Puncture Headache</condition>
  <condition>Cerebrospinal Fluid Leaks</condition>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the treatment group (morphine) will receive preservative-free morphine 0.3 mL (150 mcg) intrathecally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients randomized to the control group will receive normal saline 0.3 mL intrathecally.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.</description>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>Duramorph</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>The drug will be prepared in tuberculin syringes. After thoroughly sanitizing the catheter port with a Chloroprep wipe and allowing adequate time for drying of the Chloroprep, the anesthesiologist will first attach a 3-mL syringe to the catheter port and aspirate to a volume of 1 mL. This syringe will then be removed from the port. The study drug will then be administered through the intrathecal catheter via the tuberculin syringe. The 3-mL syringe containing the aspirate will then be injected via the catheter, effectively flushing the study drug through the catheter. The intrathecal catheter will be removed immediately following the injection.</description>
    <arm_group_label>Saline</arm_group_label>
    <other_name>Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postpartum patients following vaginal delivery

          -  Unintentional dural puncture

          -  Functioning intrathecal catheter

          -  Patients must be 18 years of age or older

          -  English speaking.

        Exclusion Criteria:

          -  History of previous PDPH

          -  Body mass index BMI &gt; 40 kg/m2

          -  History of obstructive sleep apnea (OSA)

          -  Morphine allergy

          -  Patients who receive Cesarean delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Feyce Peralta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Feyce Peralta, MD</last_name>
    <phone>312-472-3585</phone>
    <email>feyce.peralta@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert J McCarthy, PharmD</last_name>
    <phone>312-926-9015</phone>
    <email>r-mccarthy@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J McCarthy, PharmD</last_name>
      <phone>312-926-9015</phone>
      <email>r-mccarthy@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Apfel CC, Saxena A, Cakmakkaya OS, Gaiser R, George E, Radke O. Prevention of postdural puncture headache after accidental dural puncture: a quantitative systematic review. Br J Anaesth. 2010 Sep;105(3):255-63. doi: 10.1093/bja/aeq191. Epub 2010 Aug 3. Review.</citation>
    <PMID>20682567</PMID>
  </reference>
  <reference>
    <citation>Denny N, Masters R, Pearson D, Read J, Sihota M, Selander D. Postdural puncture headache after continuous spinal anesthesia. Anesth Analg. 1987 Aug;66(8):791-4.</citation>
    <PMID>3605700</PMID>
  </reference>
  <reference>
    <citation>Choi PT, Galinski SE, Takeuchi L, Lucas S, Tamayo C, Jadad AR. PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies. Can J Anaesth. 2003 May;50(5):460-9.</citation>
    <PMID>12734154</PMID>
  </reference>
  <reference>
    <citation>Choi A, Laurito CE, Cunningham FE. Pharmacologic management of postdural puncture headache. Ann Pharmacother. 1996 Jul-Aug;30(7-8):831-9. Review.</citation>
    <PMID>8826568</PMID>
  </reference>
  <reference>
    <citation>Hartopp R, Hamlyn L, Stocks G. Ten years of experience with accidental dural puncture and post-dural-puncture headache in a tertiary obstetric anaesthesia department. Int J Obstet Anesth. 2010 Jan;19(1):118. doi: 10.1016/j.ijoa.2009.06.004. Epub 2009 Nov 28.</citation>
    <PMID>19945855</PMID>
  </reference>
  <reference>
    <citation>Angle P, Tang SL, Thompson D, Szalai JP. Expectant management of postdural puncture headache increases hospital length of stay and emergency room visits. Can J Anaesth. 2005 Apr;52(4):397-402.</citation>
    <PMID>15814755</PMID>
  </reference>
  <reference>
    <citation>Carbaat PA, van Crevel H. Lumbar puncture headache: controlled study on the preventive effect of 24 hours' bed rest. Lancet. 1981 Nov 21;2(8256):1133-5.</citation>
    <PMID>6118577</PMID>
  </reference>
  <reference>
    <citation>Sudlow C, Warlow C. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2002;(2):CD001790. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD001790.</citation>
    <PMID>12076420</PMID>
  </reference>
  <reference>
    <citation>Hakim SM. Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture. Anesthesiology. 2010 Aug;113(2):413-20. doi: 10.1097/ALN.0b013e3181dfd424.</citation>
    <PMID>20613476</PMID>
  </reference>
  <reference>
    <citation>Carter BL, Pasupuleti R. Use of intravenous cosyntropin in the treatment of postdural puncture headache. Anesthesiology. 2000 Jan;92(1):272-4.</citation>
    <PMID>10638928</PMID>
  </reference>
  <reference>
    <citation>Ayad S, Demian Y, Narouze SN, Tetzlaff JE. Subarachnoid catheter placement after wet tap for analgesia in labor: influence on the risk of headache in obstetric patients. Reg Anesth Pain Med. 2003 Nov-Dec;28(6):512-5.</citation>
    <PMID>14634940</PMID>
  </reference>
  <reference>
    <citation>Charsley MM, Abram SE. The injection of intrathecal normal saline reduces the severity of postdural puncture headache. Reg Anesth Pain Med. 2001 Jul-Aug;26(4):301-5.</citation>
    <PMID>11464346</PMID>
  </reference>
  <reference>
    <citation>Cohen S, Amar D, Pantuck EJ, Singer N, Divon M. Decreased incidence of headache after accidental dural puncture in caesarean delivery patients receiving continuous postoperative intrathecal analgesia. Acta Anaesthesiol Scand. 1994 Oct;38(7):716-8.</citation>
    <PMID>7839783</PMID>
  </reference>
  <reference>
    <citation>Scavone BM, Wong CA, Sullivan JT, Yaghmour E, Sherwani SS, McCarthy RJ. Efficacy of a prophylactic epidural blood patch in preventing post dural puncture headache in parturients after inadvertent dural puncture. Anesthesiology. 2004 Dec;101(6):1422-7.</citation>
    <PMID>15564951</PMID>
  </reference>
  <reference>
    <citation>Eldor J, Gozal Y, Lavie A, Guedj P. Late postspinal headache treated with epidural morphine. Anaesthesia. 1990 Dec;45(12):1099.</citation>
    <PMID>2278354</PMID>
  </reference>
  <reference>
    <citation>Al-metwalli RR. Epidural morphine injections for prevention of post dural puncture headache. Anaesthesia. 2008 Aug;63(8):847-50. doi: 10.1111/j.1365-2044.2008.05494.x. Epub 2008 Jun 10.</citation>
    <PMID>18547293</PMID>
  </reference>
  <reference>
    <citation>Banks S, Paech M, Gurrin L. An audit of epidural blood patch after accidental dural puncture with a Tuohy needle in obstetric patients. Int J Obstet Anesth. 2001 Jul;10(3):172-6.</citation>
    <PMID>15321606</PMID>
  </reference>
  <reference>
    <citation>Olesen J, Steiner TJ. The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):808-11.</citation>
    <PMID>15145989</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>October 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2013</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Feyce Peralta</investigator_full_name>
    <investigator_title>Assistant Professor in Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Postdural puncture headache</keyword>
  <keyword>Intrathecal morphine</keyword>
  <keyword>Intrathecal catheter</keyword>
  <keyword>Headache</keyword>
  <keyword>Labor and delivery</keyword>
  <keyword>Unintentional dural puncture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Cerebrospinal Fluid Leak</mesh_term>
    <mesh_term>Cerebrospinal Fluid Rhinorrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

